Skip to content

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees

Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees of Libbs Pharmaceuticals

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05040672
Acronym
LB2008
Enrollment
280
Registered
2021-09-10
Start date
2021-06-01
Completion date
2022-07-29
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of a pharmaceutical company.

Detailed description

In Brazil, there are still few published and current studies that explore man's attention and awareness of health. Historically, women attend medical appointments and perform routine tests more frequently than men. For this is very important Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of Libbs Farmacêutica (a pharmaceutical company in Brazil).

Interventions

BEHAVIORALquestionare online application

questionare online application

Sponsors

Libbs Farmacêutica LTDA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male individuals included in the Libbs workforce; * Age 18 years or older; * Subjects who agree to participate in the study after reading and signing the Informed Consent Form.

Exclusion criteria

* There is no

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of Knowledge and Practice About Prostate Cancer e Healthy Habits1 monthAssess the subjects knowledge and practice in relation to educational campaigns aimed at prostate cancer.All the information wil be collected using a questionnaire previously approved by the ethics committee.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026